Allstate Investment Management’s ResMed RMD Stock Holding History

Allstate Investment Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$1.25M	Buy	+6,016	New	+$1.32M	0.04%	300

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Allstate Investment Management's RMD Position: Q4 2022 in Review

Allstate Investment Management opened a new position in ResMed (RMD) in Q4 2022: 6,016 shares worth $1.25M. The stake represents 0.04% of the portfolio and ranks #300 among its holdings.

730 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

Allstate Investment Management held 6,016 shares of ResMed worth $1.25M as of Q4 2022.
ResMed was a new Allstate Investment Management position in Q4 2022.
ResMed made up 0.04% of Allstate Investment Management's portfolio in Q4 2022, its #300 holding.
730 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.